The new role of microRNAs in cancer

di Perrotti, Danilo, Eiring, Anna M
Pubblicato in Future Oncol (2010)

Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemia

di Eiring, Anna M, Deininger, Michael W
Pubblicato in Genome Biol (2014)

Advances in the treatment of chronic myeloid leukemia

di Eiring, Anna M, Khorashad, Jamshid S, Morley, Kimberly, Deininger, Michael W
Pubblicazione 2011

Energy Metabolism and Drug Response in Myeloid Leukaemic Stem Cells

di Bencomo-Àlvarez, Alfonso E., Rubio, Andres J., Gonzalez, Mayra A., Eiring, Anna M.
Pubblicato in Br J Haematol (2019)

Blood cancer health disparities in the United States Hispanic population

di Bencomo-Alvarez, Alfonso E., Rubio, Andres J., Gonzalez, Mayra A., Eiring, Anna M.
Pubblicato in Cold Spring Harb Mol Case Stud (2021)

Alloreactive (CD4-independent) CD8(+) T cells jeopardize long-term survival of intrahepatic islet allografts

di Lunsford, Keri E., Jayanshankar, Kartika, Eiring, Anna M., Horne, Phillip H., Koester, Mitchel A., Gao, Donghong, Bumgardner, Ginny L.
Pubblicazione 2008

Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors

di Traer, Elie, MacKenzie, Ryan, Snead, Jennifer, Agarwal, Anupriya, Eiring, Anna M., O’Hare, Thomas, Druker, Brian J., Deininger, Michael W.
Pubblicazione 2011

Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm

di Pomicter, Anthony D., Eiring, Anna M., Senina, Anna V., Zabriskie, Matthew S., Marvin, James E., Prchal, Josef T., O’Hare, Thomas, Deininger, Michael W.
Pubblicato in Exp Hematol (2015)

A Coiled-Coil Mimetic Intercepts BCR-ABL1 Dimerization in Native and Kinase-Mutant Chronic Myeloid Leukemia

di Woessner, David W., Eiring, Anna M., Bruno, Benjamin J., Zabriskie, Matthew S., Reynolds, Kimberly R., Miller, Geoffrey D., O’Hare, Thomas, Deininger, Michael W., Lim, Carol S.
Pubblicato in Leukemia (2015)

High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2–dependent suppression of C/EBPα-driven myeloid differentiation

di Chang, Ji Suk, Santhanam, Ramasamy, Trotta, Rossana, Neviani, Paolo, Eiring, Anna M., Briercheck, Edward, Ronchetti, Mattia, Roy, Denis C., Calabretta, Bruno, Caligiuri, Michael A., Perrotti, Danilo
Pubblicazione 2007

Femoral heads from total hip arthroplasty as a source of adult hematopoietic cells

di Pomicter, Anthony D., Clair, Phillip M., Yan, Dongqing, Heaton, William L., Eiring, Anna M., Anderson, Michael B., Richards, Stephen M., Gililland, Jeremy, O’Hare, Thomas, Deininger, Michael W.
Pubblicato in Acta Haematol (2021)

Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis

di Eiring, Anna M., Neviani, Paolo, Santhanam, Ramasamy, Oaks, Joshua J., Chang, Ji Suk, Notari, Mario, Willis, William, Gambacorti-Passerini, Carlo, Volinia, Stefano, Marcucci, Guido, Caligiuri, Michael A., Leone, Gustavo W., Perrotti, Danilo
Pubblicazione 2008

COORDINATED INHIBITION OF NUCLEAR EXPORT AND BCR-ABL1 SELECTIVELY TARGETS CHRONIC MYELOID LEUKEMIA STEM CELLS

di Than, Hein, Pomicter, Anthony D., Yan, Dongqing, Beaver, Larry P., Eiring, Anna M., Heaton, William L., Senina, Anna, Clair, Phillip M., Shacham, Sharon, Mason, Clinton C., O’Hare, Thomas, Deininger, Michael W.
Pubblicato in Leukemia (2020)

Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms

di Patel, Ami B., Pomicter, Anthony D., Yan, Dongqing, Eiring, Anna M., Antelope, Orlando, Schumacher, Jonathan A., Kelley, Todd W., Tantravahi, Srinivas K., Kovacsovics, Tibor J., Shami, Paul J., O’Hare, Thomas, Deininger, Michael W.
Pubblicato in Leukemia (2020)

KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors

di Corbin, Amie S., O’Hare, Thomas, Gu, Zhimin, Kraft, Ira L., Eiring, Anna M., Khorashad, Jamshid S., Pomicter, Anthony D., Zhang, Tian Y., Eide, Christopher A., Manley, Paul W., Cortes, Jorge E., Druker, Brian J., Deininger, Michael W.
Pubblicazione 2013

RAPID CONVERSION OF CHRONIC MYELOID LEUKEMIA TO CHRONIC MYELOMONOCYTIC LEUKEMIA IN A PATIENT ON IMATINIB THERAPY

di Khorashad, Jamshid S., Tantravahi, Srinivas K., Yan, Dongqing, Mason, Clinton C., Qiao, Yi, Eiring, Anna M., Gligorich, Keith, Hein, Than, Pomicter, Anthony D., Reid, Alistair G., Kelley, Todd W., Marth, Gabor T., O'Hare, Thomas, Deininger, Michael W.
Pubblicato in Leukemia (2016)

Disarming an electrophilic warhead: Retaining potency in Tyrosine Kinase Inhibitor (TKI)-resistant CML lines, while circumventing pharmacokinetic liabilities

di Ali, Ahmed M., Gómez-Biagi, Rodolfo F., Rosa, David A., Lai, Ping-Shan, Heaton, William L., Park, JiSung, Eiring, Anna M., Vellore, Nadeem A., de Araujo, Elvin D., Ball, Dan P., Shouksmith, Andrew E., Patel, Ami B., Deininger, Michael W., O’Hare, Thomas, Gunning, Patrick T.
Pubblicato in ChemMedChem (2016)

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

di Eiring, Anna M., Khorashad, Jamshid S., Anderson, David J., Yu, Fan, Redwine, Hannah M., Mason, Clinton C., Reynolds, Kimberly R., Clair, Phillip M., Gantz, Kevin C., Zhang, Tian Y., Pomicter, Anthony D., Kraft, Ira L., Bowler, Amber D., Johnson, Kara, Mac Partlin, Mary, O’Hare, Thomas, Deininger, Michael W.
Pubblicato in Leukemia (2015)

miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

di Wallace, Jared A., Kagele, Dominique A., Eiring, Anna M., Kim, Carissa N., Hu, Ruozhen, Runtsch, Marah C., Alexander, Margaret, Huffaker, Thomas B., Lee, Soh-Hyun, Patel, Ami B., Mosbruger, Timothy L., Voth, Warren P., Rao, Dinesh S., Miles, Rodney R., Round, June L., Deininger, Michael W., O’Connell, Ryan M.
Pubblicato in Blood (2017)

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B

di Bencomo-Alvarez, Alfonso E., Rubio, Andres J., Olivas, Idaly M., Gonzalez, Mayra A., Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A., Lara, Joshua J., Barreto-Vargas, Christian, Jave-Suarez, Luis F., Nteliopoulos, Georgios, Reid, Alistair G., Milojkovic, Dragana, Druker, Brian J., Apperley, Jane, Khorashad, Jamshid S., Eiring, Anna M.
Pubblicato in Oncogene (2021)